These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 30798327
1. ADAR1 p110 Enhances Adhesion of Tumor Cells to Extracellular Matrix in Hepatocellular Carcinoma via Up-Regulating ITGA2 Expression. Yu J, Zhang C, Yu Q, Yu H, Zhang B. Med Sci Monit; 2019 Feb 24; 25():1469-1479. PubMed ID: 30798327 [Abstract] [Full Text] [Related]
2. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma. Shi L, Yan P, Liang Y, Sun Y, Shen J, Zhou S, Lin H, Liang X, Cai X. Cell Death Dis; 2017 Nov 16; 8(11):e3171. PubMed ID: 29144509 [Abstract] [Full Text] [Related]
3. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance. Mao JX, Li JJ, Lu XY, Zhong HX, Zhao YY, Zhu LY, Fu H, Ding GS, Teng F, Chen M, Guo WY. Int Immunopharmacol; 2024 Jul 30; 136():112340. PubMed ID: 38820962 [Abstract] [Full Text] [Related]
4. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients. Dong X, Chen G, Cai Z, Li Z, Qiu L, Xu H, Yuan Y, Liu XL, Liu J. Cell Physiol Biochem; 2018 Jul 30; 47(6):2602-2612. PubMed ID: 29996118 [Abstract] [Full Text] [Related]
5. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, Yuan YF, Tenen DG, Guan XY, Chen L. Gut; 2014 May 30; 63(5):832-43. PubMed ID: 23766440 [Abstract] [Full Text] [Related]
6. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Feng MX, Ma MZ, Fu Y, Li J, Wang T, Xue F, Zhang JJ, Qin WX, Gu JR, Zhang ZG, Xia Q. Mol Cancer; 2014 Oct 01; 13():226. PubMed ID: 25273699 [Abstract] [Full Text] [Related]
7. FIGNL1 Promotes Hepatocellular Carcinoma Formation via Remodeling ECM-receptor Interaction Pathway Mediated by HMMR. Wang J, Sun L, Liu Y, Zhang Y. Curr Gene Ther; 2024 Oct 01; 24(3):249-263. PubMed ID: 37929733 [Abstract] [Full Text] [Related]
8. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA. Han L, Huang C, Zhang S. Liver Int; 2019 Nov 01; 39(11):2190-2203. PubMed ID: 31365778 [Abstract] [Full Text] [Related]
9. ADAR1 promotes HBV replication through its deaminase domain. Yuan L, Jia Q, Yang S, Idris NFB, Li Y, Wang Y, Zhao Y, Hu J, Hu Y, Huang A, Tu Z. Front Biosci (Landmark Ed); 2020 Jan 01; 25(4):710-721. PubMed ID: 31585913 [Abstract] [Full Text] [Related]
10. PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas. Yang B, Hu P, Lin X, Han W, Zhu L, Tan X, Ye F, Wang G, Wu F, Yin B, Bao Z, Jiang T, Yuan J, Qiang B, Peng X. Cell Mol Life Sci; 2015 Nov 01; 72(22):4383-97. PubMed ID: 26047657 [Abstract] [Full Text] [Related]
11. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y, Tao R, Wu SS, Xu CC, Wang JL, Chen J, Yu YS, Tang ZH, Chen XH, Zang GQ. J Exp Clin Cancer Res; 2018 Jun 13; 37(1):116. PubMed ID: 29898761 [Abstract] [Full Text] [Related]
12. Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis. Zhang L, Huang Y, Ling J, Zhuo W, Yu Z, Luo Y, Zhu Y. Pathol Oncol Res; 2019 Oct 13; 25(4):1545-1552. PubMed ID: 30515639 [Abstract] [Full Text] [Related]
13. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G. Mol Pharm; 2011 Oct 03; 8(5):1538-48. PubMed ID: 21770423 [Abstract] [Full Text] [Related]
14. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism. Tang JC, Liu JH, Liu XL, Liang X, Cai XJ. World J Gastroenterol; 2015 Oct 21; 21(39):11127-40. PubMed ID: 26494967 [Abstract] [Full Text] [Related]
15. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL. J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766 [Abstract] [Full Text] [Related]
16. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. Zhou Y, Lin F, Wan T, Chen A, Wang H, Jiang B, Zhao W, Liao S, Wang S, Li G, Xu Z, Wang J, Zhang J, Ma H, Lin D, Li Q. Theranostics; 2021 Jun 17; 11(12):5926-5938. PubMed ID: 33897890 [Abstract] [Full Text] [Related]
17. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity. Ai J, Sun J, Zhou G, Zhu T, Jing L. Cell Cycle; 2020 Apr 17; 19(7):742-757. PubMed ID: 32089066 [Abstract] [Full Text] [Related]
18. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation. Liu X, Fu Y, Huang J, Wu M, Zhang Z, Xu R, Zhang P, Zhao S, Liu L, Jiang H. J Exp Clin Cancer Res; 2019 Jul 17; 38(1):315. PubMed ID: 31315644 [Abstract] [Full Text] [Related]
19. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu F, Zhang Y, Dong X, Sun B. J Exp Clin Cancer Res; 2017 Apr 27; 36(1):60. PubMed ID: 28449718 [Abstract] [Full Text] [Related]
20. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma. Ma J, Li T, Han X, Yuan H. J Cancer Res Clin Oncol; 2018 Feb 27; 144(2):205-214. PubMed ID: 29127494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]